NXS — Next Science Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- AU$42.36m
- AU$48.62m
- $22.82m
Brief: Next Science Posts 1Q Direct Product Sales Of $4.3M
Brief: Next Science Posts FY Loss Attributable Of $16.3 Mln
Brief: Next Science Says Reaffirm FY24 Guidance For Revenue Of $36 Mln-$40 Mln
Brief: Next Science Posts FY23 Revenue Of $22.2M
Brief: Next Science Says Continue To Expect Will Achieve Positive EBITDA & Cashflow During 2HFY24
Brief: Next Science Says 3QFY23 Product Sales (Unaudited) Increased 60% YoY To US$5.0 Mln
Australia's Next Science hits record low as HY EBITDA loss widens
Brief: Next Science Posts 1H23 Underlying EBITDA Loss Of $8.3M
Brief: Next Science Seeks Trading Halt
Brief: Next Science Appoints Aileen Stockburger As Chair
Brief: Next Science Says 2QFY23 Product Sales (Unaudited) $5.6M
Australia's Next Science jumps on solid sales forecast
Brief: Next Science Sees Unaudited Product Sales For 2Q To Be Above $5.6M
Australia's Next Science appoints new CEO, shares rise
Brief: Next Science Announces Appointment Of Harry Thomas Hall, Iv As New Managing Director And CEO
Brief: Next Science Says Q1 Product Sales (Unaudited) Increased 130%
Brief: Next Science Posts Loss After Income Tax Expense For Year $12.7 Million
Brief: Next Science Says To Deliver Increasing Patient Access Across Product Portfolio Through Fy23
Brief: Next Science Says Full Year Revenue(Unaudited) $11.7 Mln